Brachial Plexus Block
Cross-source consensus on Brachial Plexus Block from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Benefits
Risks & contraindications
Highlighted claims
- Brachial plexus block is described as the gold-standard analgesic strategy for open elbow arthrolysis. — Liposomal bupivacaine versus standard ropivacaine for pain control in adults receiving continuous supraclavicular brachial plexus blocks for open elbow arthrolysis: study protocol for a randomised controlled non-inferiority clinical trial
- Single-injection brachial plexus blocks are limited by short local anesthetic duration and possible rebound pain. — Liposomal bupivacaine versus standard ropivacaine for pain control in adults receiving continuous supraclavicular brachial plexus blocks for open elbow arthrolysis: study protocol for a randomised controlled non-inferiority clinical trial
- Continuous catheter analgesia has limitations including displacement, nerve susceptibility, infection risk, and high operator-skill requirements. — Liposomal bupivacaine versus standard ropivacaine for pain control in adults receiving continuous supraclavicular brachial plexus blocks for open elbow arthrolysis: study protocol for a randomised controlled non-inferiority clinical trial
- Continuous brachial plexus catheterisation improves analgesia duration and effectiveness. — Liposomal bupivacaine versus standard ropivacaine for pain control in adults receiving continuous supraclavicular brachial plexus blocks for open elbow arthrolysis: study protocol for a randomised controlled non-inferiority clinical trial